| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 7,935 | 7,100 | 12,581 |
|
Selling General and Administrative | 14,104 | 14,307 | 9,490 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(22,039)
|
(21,407)
|
(22,071)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 3,088 | 16 | 5,060 |
|
Earnings Before Interest And Taxes | (18,951) | (21,391) | (18,354) |
|
Interest Expense | 795 | 1,125 | 848 |
|
Income Before Tax | (19,746) | (22,516) | (19,202) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (19,746) | (22,516) | (17,859) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
| 4,000 |
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(19,746)
|
(22,516)
|
(13,859)
| | Preferred Stock And Other Adjustments |
-
|
-
| (3,104) | | |
Net Income Applicable To Common Shares
|
(19,746)
|
(22,516)
|
(16,963)
|
|